Endoscopic treatment of gastrointestinal neuroendocrine neoplasms based on full-thickness resection technique

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029378

Enrollment

Unknown

Registered

2020-01-27

Start date

2020-02-10

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroendocrine neoplasms of Gastrointestinal tract

Interventions

1:EFTR

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 70 years, Chinese patient; 2. Be able to answer questions correctly; 3. Sign informed consent; 4. Suspected rectal NET confirmed by colonoscopy or EUS.

Exclusion criteria

Exclusion criteria: 1. Severe heart, lung, liver, kidney and metabolic diseases, electrolyte disorders; 2. The patient could not tolerate the gastroscopy; 3. Take anticoagulants such as aspirin and forward in the near future; 4. Operation contraindications; 5. Metastasis was confirmed by preoperative examination or Tumor diameter greater than 2cm.

Design outcomes

Primary

Measure	Time frame
surgical margin;	—

Countries

China

Contacts

Public ContactZhou Yinbin

Departement of Gastroenterology, Army Medical Center of PLA

24956934@qq.com+86 13637819353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026